RxDoctor Payments Data

Amanda Brenneman

Family · Marion, IANPI 1639658800

Payments from drug & device makers

$1,103in general payments, 2019–2025

Across 69 payments — averaging $15.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$296
  • AbbVie$265
  • Novo Nordisk$126
  • AstraZeneca$85
  • Abbott$64
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$43
  • plus $225 from 9 others

What the payments were for

  • Food & beverage$1,103100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,103 in reported general payments places this provider in the 80th percentile of 1,268 family providers in Iowa.

See all family providers in Iowa

Medicare billing

Part B allowed, 2024
$94,559
Medicare patients
141
Services billed
2,758

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin21$28,972
OzempicSemaglutide23$28,077
MounjaroTirzepatide17$26,678
EliquisApixaban37$25,892
FarxigaDapagliflozin Propanediol11$14,968
TrulicityDulaglutide13$12,780
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$4,546
Arnuity ElliptaFluticasone Furoate20$4,446
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$2,155
Esomeprazole Magnesium12$2,150
Levothyroxine Sodium242$1,518
Atorvastatin Calcium199$1,396
Gabapentin73$1,376
Duloxetine Hcl58$1,316
ValacyclovirValacyclovir Hcl29$1,238

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$30$39,45830 claims
Boehringer IngelheimJardiance$27$28,97221 claims
Novo NordiskOzempic$126$28,07723 claims
PfizerEliquis$296$25,89237 claims
AstraZenecaFarxiga$85$14,96811 claims
GSKArnuity Ellipta$17$4,44620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,268 family providers in Iowa.

Other family in Marion

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →